Who owns Cingulate Inc.?
The parent company, the largest shareholders that report their holdings, the funds that own Cingulate Inc. and what its insiders traded, each from the filing that states it.
The short answer
Cingulate Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders.
41 institutional investors that report to the SEC on Form 13F held 19.6% of its shares on Sep 30, 2026.
The largest of them was Vanguard Capital Management LLC with 3.93%, followed by Susquehanna International Group, LLP (1.54%) and Raymond James Financial Inc (1.48%).
11 mutual funds held 4.7% of the company in their latest reports (the newest of Jun 30, 2026); the largest position was Vanguard Total Stock Market Index Fund's.
In the last 12 months its insiders reported 5 purchases worth $1 M and no sales on SEC Form 4.
Newest figure: Sep 30, 2026.
Holdings reported on SEC Form 13F for the quarter ended Sep 30, 2026: 41 holders, 19.6% of the shares together.
| # | Holder | Of the shares | Value | Shares | Change in the quarter |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management LLC | 3.93% | $3 M | 570,873 | 0.0% |
| 2 | Susquehanna International Group, LLP | 1.54% | $1 M | 223,866 | new |
| 3 | Raymond James Financial Inc | 1.48% | $1 M | 214,898 | +28.8% |
| 4 | Renaissance Technologies LLC | 1.28% | $1 M | 186,384 | +46.2% |
| 5 | Citadel Advisors LLC | 1.22% | $1 M | 176,930 | new |
| 6 | Marshall Wace, LLP | 1.10% | $1 M | 160,380 | new |
| 7 | Kestra Advisory Services, LLC | 1.08% | $1 M | 156,500 | +3.3% |
| 8 | Geode Capital Management, LLC | 1.05% | $1 M | 152,820 | +5.7% |
| 9 | Bolton Securities Corporation | 0.96% | $1 M | 139,000 | 0.0% |
| 10 | Chicago Partners Investment Group LLC | 0.76% | $1 M | 110,737 | -41.2% |
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Filings read up to Nov 16, 2026; the quarter is still being filed (99% of last quarter's holders so far). People who hold shares in their own name, such as founders, are not in 13F reports
How ownership moved#
Institutions held 19.6% of Cingulate Inc. at Sep 30, 2026, up 7.02 points from Jun 30, 2026; 8 more institutions.
| Quarter end | Institutions | Share of the company | Shares bought | Shares sold | Positions opened | Positions closed |
|---|---|---|---|---|---|---|
| Sep 30, 2026(still being filed) | 41 | 19.6% | 1.0 M | 85,289 | 14 | 7 |
| Jun 30, 2026 | 33 | 12.6% | 929,351 | 110,203 | 10 | — |
| Mar 31, 2026 | 27 | 10.2% | — | — | — | — |
| Dec 31, 2025 | 17 | 4.4% | — | — | — | — |
| Sep 30, 2025 | 12 | 4.3% | — | — | — | — |
| Jun 30, 2025 | 15 | 4.3% | — | — | — | — |
| Mar 31, 2025 | 9 | 3.5% | — | — | — | — |
| Dec 31, 2024 | 9 | 2.4% | — | — | — | — |
| Sep 30, 2024 | 10 | 1.6% | — | — | — | — |
Bought most, quarter to Sep 30, 2026
- Renaissance Technologies LLC+58,884
- Raymond James Financial Inc+48,000
- UBS Group AG+43,023
- Vanguard Fiduciary Trust Co+9,671
- Geode Capital Management, LLC+8,184
- Kestra Advisory Services, LLC+5,000
- State Street Corp+4,300
- Prospera Financial Services Inc+2,350
Sold most
- Chicago Partners Investment Group LLC−77,692
- Jane Street Group, LLC−7,258
- Morgan Stanley−339
New positions (shares held)
- Susquehanna International Group, LLP223,866
- Citadel Advisors LLC176,930
- Marshall Wace, LLP160,380
- North Star Investment Management Corp.100,000
- Simplex Trading, LLC70,978
- Captrust Financial Advisors42,123
- Bank Of America Corp /de/27,329
- Spark Investment Management LLC20,400
Insiders' open-market purchases (up) and sales (down), by quarter
Source: SEC Form 13F data sets and Forms 4 and 5. Institutions report three months after each quarter; a quarter's purchases and sales add up each institution's change since its report for the quarter before. Insiders' trades count open-market purchases and sales only, in the company's reporting currency. 11 mutual funds and ETFs hold Cingulate Inc. in their latest reports: 5 new, 5 adding, 0 cutting.
11 funds held 4.7% of the company in their latest reports. Fund holdings are part of what their managers report on Form 13F, so do not add the two.
| Fund | Manager | Country | Of the company | Value | Report of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 2.71% | $2 M | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 1.10% | $1 M | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | Fidelity Management & Research Company LLC | 🇺🇸 | 0.29% | $0 M | May 31, 2026 |
| iShares Micro-Cap ETF | BlackRock Fund Advisors | 🇺🇸 | 0.19% | $0 M | Jun 30, 2026 |
| Fidelity Total Market Index Fund | Fidelity Management & Research Company LLC | 🇺🇸 | 0.15% | $0 M | May 31, 2026 |
Source: Fund portfolios filed with regulators (SEC Form N-PORT and others) · as of Jun 30, 2026
- Purchases
- 5
- Sales
- 0
- Bought
- $1 M
- Sold
- $0 M
Questions and answers#
Who owns Cingulate Inc.?
Cingulate Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders. 41 institutional investors that report to the SEC on Form 13F held 19.6% of its shares on Sep 30, 2026. The largest of them was Vanguard Capital Management LLC with 3.93%, followed by Susquehanna International Group, LLP (1.54%) and Raymond James Financial Inc (1.48%).
Who is the largest shareholder of Cingulate Inc.?
Among investors that file SEC Form 13F, Vanguard Capital Management LLC was the largest on Sep 30, 2026, with 3.93% of the shares. Founders, executives and other people who hold shares in their own name report them on SEC Forms 3, 4 and 5 and in the proxy statement, not on Form 13F, so they are not in this ranking.
How much of Cingulate Inc. do institutional investors own?
41 institutional investors that report to the SEC on Form 13F held 19.6% of its shares on Sep 30, 2026.
Which mutual funds own Cingulate Inc.?
11 mutual funds held 4.7% of the company in their latest reports (the newest of Jun 30, 2026); the largest position was Vanguard Total Stock Market Index Fund's. Funds' holdings are part of what their managers report on Form 13F, so the two shares overlap.
Sources#
Every figure on this page comes from these, with the date shown next to it.
- SEC Form 13F holdings reports
- Fund portfolios filed with regulators (SEC Form N-PORT, Brazil CVM, Sweden Finansinspektionen, Indian fund houses)
- SEC Forms 3, 4 and 5 (insider transactions)
More about Cingulate Inc.#
Questions people ask
Compare head to head
Similar companies by size and industry
- Regenxbio Inc.$513 M
- Pharmicell Co., Ltd.$514 M
- Pulike Biological Engineering, Inc.$524 M
- Contineum Therapeutics, Inc.$534 M
- Entera Bio Ltd.$543 M
- Arvinas, Inc.$544 M